The outcomes verify conclusions drawn by Bagli et al. [one], who carried out a examine that provided 10 patients diagnosed with CRAO who obtained HBOT. As well as acquiring 20 sessions of HBOT, oral acetazolamide and topical beta-blockers ended up administered into the patients with the earliest attainable time.OPDIVO + YERVOY, with chemotherapy, i